Connecting you to content on EBSCOhost

Works matching IS 20406207 AND DT 2017 AND VI 8 AND IP 1

Results: 4

1

Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib.

Published in:

Therapeutic Advances in Hematology, 2017, v. 8, n. 1, p. 3, doi. 10.1177/2040620716678118

By:

Ailawadhi, Sikander;
Akard, Luke P.;
Miller, Carole B.;
Jillella, Anand;
DeAngelo, Daniel J.;
Ericson, Solveig G.;
Lin, Felice;
Warsi, Ghulam;
Radich, Jerald

Publication type:

Article

2

An update on the role of daratumumab in the treatment of multiple myeloma.

Published in:

Therapeutic Advances in Hematology, 2017, v. 8, n. 1, p. 28, doi. 10.1177/2040620716677523

By:

Costello, Caitlin

Publication type:

Article

3

Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma.

Published in:

Therapeutic Advances in Hematology, 2017, v. 8, n. 1, p. 13, doi. 10.1177/2040620716676256

By:

Sethi, Tarsheen;
Nguyen, Van;
Li, Shaoying;
Morgan, David;
Greer, John;
Reddy, Nishitha

Publication type:

Article

4

Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes.

Published in:

Therapeutic Advances in Hematology, 2017, v. 8, n. 1, p. 21, doi. 10.1177/2040620716674677

By:

Navada, Shyamala C.;
Silverman, Lewis R.

Publication type:

Article